Post-approval studies (Phase 4)Study completedNCT02584660
What this trial is testing
Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department
Who this might be right for
Pulmonary Embolism
Janssen Scientific Affairs, LLC 114